Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.71% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 31.42% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 33.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.17% |
| Dec 31, 2025 | 12.47% |
| Sep 30, 2025 | 26.91% |
| Jun 30, 2025 | 7.45% |
| Mar 31, 2025 | -26.98% |
| Dec 31, 2024 | 3.83% |
| Sep 30, 2024 | -18.39% |
| Jun 30, 2024 | -34.60% |
| Mar 31, 2024 | -23.35% |
| Dec 31, 2023 | -16.36% |
| Sep 30, 2023 | -49.36% |
| Jun 30, 2023 | -43.82% |
| Mar 31, 2023 | -65.29% |
| Dec 31, 2022 | -53.93% |
| Sep 30, 2022 | -37.20% |
| Jun 30, 2022 | -15.97% |
| Mar 31, 2022 | -12.98% |
| Dec 31, 2021 | -35.02% |
| Sep 30, 2021 | -36.62% |
| Jun 30, 2021 | -36.14% |
| Mar 31, 2021 | -17.75% |
| Dec 31, 2020 | -40.84% |
| Sep 30, 2020 | -84.96% |
| Jun 30, 2020 | -12.08% |
| Mar 31, 2020 | -9.48% |
| Dec 31, 2019 | -22.09% |
| Sep 30, 2019 | -12.52% |
| Jun 30, 2019 | -25.43% |
| Mar 31, 2019 | 6.65% |
| Dec 31, 2018 | -14.85% |
| Sep 30, 2018 | 5.93% |
| Jun 30, 2018 | 11.11% |
| Mar 31, 2018 | -14.75% |
| Dec 31, 2017 | 9.36% |
| Sep 30, 2017 | 39.04% |
| Jun 30, 2017 | 8.94% |
| Mar 31, 2017 | 5.54% |
| Dec 31, 2016 | -2.16% |
| Sep 30, 2016 | -7.75% |
| Jun 30, 2016 | -31.33% |